Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paricalcitol for Anemia of Inflammation in Dialysis
NCT02876211Phase 4Terminated
- Sponsor
- Hospital Universitari Son Espases
- Start
- Dec 2014
- Primary completion
- Aug 2022
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of paricalcitol in anemia of inflammation (AI), sponsored by Hospital Universitari Son Espases. Started Dec 2014; status: terminated.
02
Drugs
paricalcitol
03
Conditions
anemia of inflammation (AI)
Beyond the preview
Go deeper on NCT02876211.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02876211.